{"id":17971,"date":"2025-07-29T19:57:59","date_gmt":"2025-07-29T19:57:59","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/arisglobal-achieves-strong-global-growth-and-continued-innovation-in-first-half-2025\/"},"modified":"2025-07-29T19:57:59","modified_gmt":"2025-07-29T19:57:59","slug":"arisglobal-achieves-strong-global-growth-and-continued-innovation-in-first-half-2025","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=17971","title":{"rendered":"ArisGlobal Achieves Strong Global Growth and Continued Innovation in First Half 2025"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1510670\/5435511\/ArisGlobal_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><i>Expanding Impact of LifeSphere\u00ae NavaX\u2122 Across the Industry, 27 Go-Lives, and New Global Pharma Adoptions<\/i><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">BOSTON<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 29, 2025<\/span><\/span> \/PRNewswire\/ &#8212; ArisGlobal, an AI-first technology company and creator of\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3088869662&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2F&amp;a=LifeSphere%C2%AE\" target=\"_blank\" rel=\"nofollow\">LifeSphere\u00ae<\/a>, today announced significant momentum in the first half of 2025, driven by continued product innovation via LifeSphere\u00ae NavaX\u2122, strong new customer acquisition, and rapid global deployments.<\/p>\n<p><b>Operationalizing AI with LifeSphere\u00ae NavaX\u2122<\/b><br \/>ArisGlobal now counts <b>seven global pharmaceutical companies<\/b> leveraging LifeSphere\u00ae NavaX\u2122 across safety operations \u2014 a clear signal of growing industry confidence in GenAI-powered automation. Recent customer milestones include:<\/p>\n<ul type=\"disc\">\n<li><b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1159687902&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fglobal-pharma-leader-accelerates-ai-powered-case-processing-with-lifesphere-navax%2F&amp;a=Top+10+global%C2%A0pharma\" target=\"_blank\" rel=\"nofollow\">Top 10 global\u00a0pharma<\/a><\/b><b>:<\/b> Recently deployed NavaX across its safety case intake processes at global scale. Within weeks of go-live, the customer reported meaningful efficiency gains and strong early data accuracy.<\/li>\n<li><b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1161717285&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fboehringer-ingelheim-harnesses-genai-to-transform-case-intake-with-lifesphere-navax%2F&amp;a=Boehringer+Ingelheim\" target=\"_blank\" rel=\"nofollow\">Boehringer Ingelheim<\/a><\/b><b>:<\/b>\u00a0Successfully implemented NavaX for safety case intake, achieving 90% data accuracy within weeks of go-live\u2014dramatically reducing manual effort and improving efficiency in early rollout.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3907425589&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fseventh-global-life-sciences-company-selects-lifesphere-navax-for-genai-driven-case-processing%2F&amp;a=Additional+Top+25+global%C2%A0pharma+companies\" target=\"_blank\" rel=\"nofollow\"><b>Additional Top 25 global\u00a0pharma companies<\/b><\/a><b>:<\/b> Multiple companies selected NavaX in H1 2025 to modernize safety case intake processes, with implementations now underway.<\/li>\n<\/ul>\n<p>NavaX is powering a growing number of real-world applications across pharmacovigilance \u2014 from advanced case intake to MedDRA coding, signal detection, and safety document generation. These AI-driven capabilities help organizations reduce manual effort, accelerate timelines, and unlock actionable insights, while ensuring regulatory compliance and audit readiness. These deployments reflect an industry-wide shift from isolated AI experimentation to full-scale, enterprise adoption.<\/p>\n<p>ArisGlobal signed the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1680305083&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-signs-eu-ai-pact%2F&amp;a=EU+AI+Pact\" target=\"_blank\" rel=\"nofollow\">EU AI Pact<\/a> \u2014 a key step in the company&#8217;s ongoing commitment to responsible AI innovation. The initiative, led by the European Commission, promotes ethical, transparent, and regulation-ready AI deployment across the industry.<\/p>\n<p>&#8220;We&#8217;re seeing a fundamental shift \u2014 customers are no longer experimenting with AI; they&#8217;re operationalizing it at scale,&#8221; said <span class=\"xn-person\">Jason Bryant<\/span>, VP of Product Management, AI &amp; Data at ArisGlobal. &#8220;With NavaX, we&#8217;re delivering proven, production-ready AI that&#8217;s embedded into real-world workflows, helping safety and regulatory teams work faster, reduce cost, and make smarter decisions\u2014right now, not years from now.&#8221;<\/p>\n<p><b>Customer Acquisition and Expansion<\/b><br \/>Demand for LifeSphere continued to rise as life sciences organizations turned to ArisGlobal for proven, AI-enabled safety and regulatory solutions that are ready to meet today&#8217;s rising case volumes and regulatory complexity. In the first half of 2025, ArisGlobal recorded:<\/p>\n<ul type=\"disc\">\n<li>Four net new\u00a0pharma LifeSphere customers added, including Top 50 organizations;<\/li>\n<li>31% of existing\u00a0LifeSphere customers expanded their business with ArisGlobal, reflecting continued confidence in the platform and value of NavaX-enabled capabilities.<\/li>\n<\/ul>\n<p>ArisGlobal&#8217;s <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=4287798349&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-introduces-shared-success-model-to-guarantee-automation-return-on-investment%2F&amp;a=Shared+Success+Model\" target=\"_blank\" rel=\"nofollow\">Shared Success Model<\/a><\/b>, introduced in <span class=\"xn-chron\">April 2025<\/span>, has played a role in this momentum. The model guarantees automation-driven return on investment (ROI) for pharmaceutical customers and is designed to de-risk technology adoption by aligning ArisGlobal&#8217;s success directly with its customers&#8217;.<\/p>\n<p>&#8220;Pharmacovigilance and regulatory teams are under more pressure than ever \u2014 from increasing global case volumes to tighter reporting timelines and complex compliance requirements,&#8221; said <span class=\"xn-person\">Steve Nuckols<\/span>, Chief Customer Officer at ArisGlobal. &#8220;Organizations don&#8217;t have time to wait for innovation that&#8217;s still on the roadmap \u2014 they need proven, enterprise-ready solutions today. That&#8217;s where LifeSphere delivers. Our customers are going live on NavaX in as little as three to six months, and they&#8217;re seeing meaningful, measurable outcomes from day one.&#8221;<\/p>\n<p><b>Global Implementations and Consulting Success<\/b><br \/>ArisGlobal experts continue to excel in planning, implementing, and deploying LifeSphere solutions worldwide. In the first half of 2025, the company delivered strong execution performance, including:<\/p>\n<ul type=\"disc\">\n<li>27 total go-lives across\u00a0LifeSphere Safety and Regulatory, representing a 12.5% YoY increase;<\/li>\n<li>10 go-lives in APAC, a 233%\u00a0YoY increase;<\/li>\n<li>Implementations for three of the Top 20 global pharmaceutical companies.<\/li>\n<\/ul>\n<p>&#8220;In today&#8217;s regulatory landscape, life sciences companies need implementation partners who understand the urgency \u2014 and the complexity \u2014 of modern safety and regulatory systems,&#8221; said Raj Hattarki, Chief Operating Officer at ArisGlobal. &#8220;Our consulting teams combine speed with deep domain expertise, working closely with third-party vendors to execute global go-lives with precision momentum is a testament to our ability to deliver scale, quality, and value \u2014 all at once.&#8221;<\/p>\n<p><b>Product Innovation and AI-Powered Automation<\/b><br \/>ArisGlobal continued to deliver tangible innovation in H1 2025, expanding its AI-driven product suite to address critical pharmacovigilance and regulatory challenges with speed and precision. LifeSphere\u00ae NavaX\u2122 has rapidly evolved into an enterprise-ready solution, with growing adoption and embedded capabilities delivering measurable gains in productivity, compliance, and decision-making.<\/p>\n<p>ArisGlobal introduced several new product innovations, including:<\/p>\n<ul type=\"disc\">\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=490648651&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2F&amp;a=LifeSphere%C2%AE+Unify\" target=\"_blank\" rel=\"nofollow\">LifeSphere\u00ae Unify<\/a>\u00a0\u2013 A next-generation R&amp;D compliance platform that brings Safety, Regulatory, Medical Affairs, and Quality into one cohesive ecosystem, enabling unparalleled interoperability, visibility, and decision support.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=66713719&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-announces-lifesphere-unify-navax-insights-and-advanced-compliance-docs%2F&amp;a=NavaX+Insights\" target=\"_blank\" rel=\"nofollow\">NavaX Insights<\/a>\u00a0\u2013 A contextual analytics engine that automatically synthesizes information from multiple structured and unstructured sources, surfacing hidden trends, emerging risks, and actionable signals across PV and Regulatory domains.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1143080633&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-launches-new-navax-agent-meddra-coding-powered-by-agentic-ai%2F&amp;a=NavaX+Agent+for+MedDRA+Coding\" target=\"_blank\" rel=\"nofollow\">NavaX Agent for MedDRA Coding<\/a>\u00a0\u2013 An agentic AI capability that mimics expert user behavior to deliver over 80% coding automation, reduce manual workloads, and ensure audit-ready traceability in the medical coding process.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1736081334&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2Fsafety%2Fadvanced-compliance-docs%2F&amp;a=Advanced+Compliance+Docs\" target=\"_blank\" rel=\"nofollow\">Advanced Compliance Docs<\/a>\u00a0\u2013 A purpose-built automation engine for safety and regulatory documentation, streamlining the creation, storage, and collaboration of complex materials like PSMFs, PVAs, and aggregate safety reports.<\/li>\n<\/ul>\n<p>These additions reflect ArisGlobal&#8217;s broader commitment to delivering practical, production-ready AI use cases \u2014 with most modules able to be implemented in as little as three to six months.<\/p>\n<p>&#8220;Our approach to product development is grounded in solving real problems that our customers are facing today,&#8221; said <span class=\"xn-person\">Ann-Marie Orange<\/span>, CIO and Global Head of R&amp;D at ArisGlobal. &#8220;We&#8217;re moving fast, but with purpose \u2014 applying AI where it makes the biggest difference, and doing so in a way that ensures trust, traceability, and tangible results.&#8221;<\/p>\n<p><b>Leadership and Strategic Investment<\/b><br \/>In <span class=\"xn-chron\">May 2025<\/span>, ArisGlobal <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=2380997884&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Flucinda-smith-appointed-as-chief-safety-product-officer-at-arisglobal%2F&amp;a=appointed+Lucinda+Smith\" target=\"_blank\" rel=\"nofollow\">appointed <span class=\"xn-person\">Lucinda Smith<\/span><\/a> as Chief Safety Product Officer. Formerly Global Head of Safety Operations at Roche, Smith brings a deep understanding of the challenges facing today&#8217;s pharmacovigilance teams \u2014 and how technology can help address them. Her leadership reflects ArisGlobal&#8217;s continued investment in domain expertise and customer-centric product development.<\/p>\n<p>&#8220;Across the industry, regulatory pressure is intensifying, case volumes are climbing, and cost constraints are pushing teams to rethink how they work,&#8221; said <span class=\"xn-person\">Aman Wasan<\/span>, Chief Executive Officer of ArisGlobal. &#8220;Organizations are looking to simplify their IT ecosystems and turn to automation not just as a future goal, but as a necessity. Our AI-first approach \u2014 and our ability to help customers operationalize AI in real, tangible ways \u2014 is exactly why we&#8217;re seeing such strong customer adoption, and why the industry&#8217;s best talent is coming to ArisGlobal.&#8221;<\/p>\n<p><b>About ArisGlobal<\/b><br \/>ArisGlobal, an innovative life sciences technology company and creator of LifeSphere\u00ae, is transforming how today&#8217;s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in <span class=\"xn-location\">the United States<\/span>, ArisGlobal has regional offices in <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">India<\/span>, <span class=\"xn-location\">Japan<\/span>, and <span class=\"xn-location\">China<\/span>. For more updates, follow ArisGlobal on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1844092706&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faris-global%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>. <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3166715220&amp;u=https%3A%2F%2Fwww.arisglobal.com%2F&amp;a=www.arisglobal.com\" target=\"_blank\" rel=\"nofollow\">www.arisglobal.com<\/a>.\u00a0<\/p>\n<p>Logo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=88688840&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1510670%2F5435511%2FArisGlobal_Logo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1510670%2F5435511%2FArisGlobal_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnasia.com\/media2\/1510670\/5435511\/ArisGlobal_Logo.jpg?p=medium600<\/a><\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1510670\/5435511\/ArisGlobal_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><i>Expanding Impact of LifeSphere\u00ae NavaX\u2122 Across the Industry, 27 Go-Lives, and New Global Pharma Adoptions<\/i><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">BOSTON<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 29, 2025<\/span><\/span> \/PRNewswire\/ &#8212; ArisGlobal, an AI-first technology company and creator of\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3088869662&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2F&amp;a=LifeSphere%C2%AE\" target=\"_blank\" rel=\"nofollow\">LifeSphere\u00ae<\/a>, today announced significant momentum in the first half of 2025, driven by continued product innovation via LifeSphere\u00ae NavaX\u2122, strong new customer acquisition, and rapid global deployments.<\/p>\n<p><b>Operationalizing AI with LifeSphere\u00ae NavaX\u2122<\/b><br \/>ArisGlobal now counts <b>seven global pharmaceutical companies<\/b> leveraging LifeSphere\u00ae NavaX\u2122 across safety operations \u2014 a clear signal of growing industry confidence in GenAI-powered automation. Recent customer milestones include:<\/p>\n<ul type=\"disc\">\n<li><b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1159687902&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fglobal-pharma-leader-accelerates-ai-powered-case-processing-with-lifesphere-navax%2F&amp;a=Top+10+global%C2%A0pharma\" target=\"_blank\" rel=\"nofollow\">Top 10 global\u00a0pharma<\/a><\/b><b>:<\/b> Recently deployed NavaX across its safety case intake processes at global scale. Within weeks of go-live, the customer reported meaningful efficiency gains and strong early data accuracy.<\/li>\n<li><b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1161717285&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fboehringer-ingelheim-harnesses-genai-to-transform-case-intake-with-lifesphere-navax%2F&amp;a=Boehringer+Ingelheim\" target=\"_blank\" rel=\"nofollow\">Boehringer Ingelheim<\/a><\/b><b>:<\/b>\u00a0Successfully implemented NavaX for safety case intake, achieving 90% data accuracy within weeks of go-live\u2014dramatically reducing manual effort and improving efficiency in early rollout.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3907425589&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Fseventh-global-life-sciences-company-selects-lifesphere-navax-for-genai-driven-case-processing%2F&amp;a=Additional+Top+25+global%C2%A0pharma+companies\" target=\"_blank\" rel=\"nofollow\"><b>Additional Top 25 global\u00a0pharma companies<\/b><\/a><b>:<\/b> Multiple companies selected NavaX in H1 2025 to modernize safety case intake processes, with implementations now underway.<\/li>\n<\/ul>\n<p>NavaX is powering a growing number of real-world applications across pharmacovigilance \u2014 from advanced case intake to MedDRA coding, signal detection, and safety document generation. These AI-driven capabilities help organizations reduce manual effort, accelerate timelines, and unlock actionable insights, while ensuring regulatory compliance and audit readiness. These deployments reflect an industry-wide shift from isolated AI experimentation to full-scale, enterprise adoption.<\/p>\n<p>ArisGlobal signed the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1680305083&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-signs-eu-ai-pact%2F&amp;a=EU+AI+Pact\" target=\"_blank\" rel=\"nofollow\">EU AI Pact<\/a> \u2014 a key step in the company&#8217;s ongoing commitment to responsible AI innovation. The initiative, led by the European Commission, promotes ethical, transparent, and regulation-ready AI deployment across the industry.<\/p>\n<p>&#8220;We&#8217;re seeing a fundamental shift \u2014 customers are no longer experimenting with AI; they&#8217;re operationalizing it at scale,&#8221; said <span class=\"xn-person\">Jason Bryant<\/span>, VP of Product Management, AI &amp; Data at ArisGlobal. &#8220;With NavaX, we&#8217;re delivering proven, production-ready AI that&#8217;s embedded into real-world workflows, helping safety and regulatory teams work faster, reduce cost, and make smarter decisions\u2014right now, not years from now.&#8221;<\/p>\n<p><b>Customer Acquisition and Expansion<\/b><br \/>Demand for LifeSphere continued to rise as life sciences organizations turned to ArisGlobal for proven, AI-enabled safety and regulatory solutions that are ready to meet today&#8217;s rising case volumes and regulatory complexity. In the first half of 2025, ArisGlobal recorded:<\/p>\n<ul type=\"disc\">\n<li>Four net new\u00a0pharma LifeSphere customers added, including Top 50 organizations;<\/li>\n<li>31% of existing\u00a0LifeSphere customers expanded their business with ArisGlobal, reflecting continued confidence in the platform and value of NavaX-enabled capabilities.<\/li>\n<\/ul>\n<p>ArisGlobal&#8217;s <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=4287798349&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-introduces-shared-success-model-to-guarantee-automation-return-on-investment%2F&amp;a=Shared+Success+Model\" target=\"_blank\" rel=\"nofollow\">Shared Success Model<\/a><\/b>, introduced in <span class=\"xn-chron\">April 2025<\/span>, has played a role in this momentum. The model guarantees automation-driven return on investment (ROI) for pharmaceutical customers and is designed to de-risk technology adoption by aligning ArisGlobal&#8217;s success directly with its customers&#8217;.<\/p>\n<p>&#8220;Pharmacovigilance and regulatory teams are under more pressure than ever \u2014 from increasing global case volumes to tighter reporting timelines and complex compliance requirements,&#8221; said <span class=\"xn-person\">Steve Nuckols<\/span>, Chief Customer Officer at ArisGlobal. &#8220;Organizations don&#8217;t have time to wait for innovation that&#8217;s still on the roadmap \u2014 they need proven, enterprise-ready solutions today. That&#8217;s where LifeSphere delivers. Our customers are going live on NavaX in as little as three to six months, and they&#8217;re seeing meaningful, measurable outcomes from day one.&#8221;<\/p>\n<p><b>Global Implementations and Consulting Success<\/b><br \/>ArisGlobal experts continue to excel in planning, implementing, and deploying LifeSphere solutions worldwide. In the first half of 2025, the company delivered strong execution performance, including:<\/p>\n<ul type=\"disc\">\n<li>27 total go-lives across\u00a0LifeSphere Safety and Regulatory, representing a 12.5% YoY increase;<\/li>\n<li>10 go-lives in APAC, a 233%\u00a0YoY increase;<\/li>\n<li>Implementations for three of the Top 20 global pharmaceutical companies.<\/li>\n<\/ul>\n<p>&#8220;In today&#8217;s regulatory landscape, life sciences companies need implementation partners who understand the urgency \u2014 and the complexity \u2014 of modern safety and regulatory systems,&#8221; said Raj Hattarki, Chief Operating Officer at ArisGlobal. &#8220;Our consulting teams combine speed with deep domain expertise, working closely with third-party vendors to execute global go-lives with precision momentum is a testament to our ability to deliver scale, quality, and value \u2014 all at once.&#8221;<\/p>\n<p><b>Product Innovation and AI-Powered Automation<\/b><br \/>ArisGlobal continued to deliver tangible innovation in H1 2025, expanding its AI-driven product suite to address critical pharmacovigilance and regulatory challenges with speed and precision. LifeSphere\u00ae NavaX\u2122 has rapidly evolved into an enterprise-ready solution, with growing adoption and embedded capabilities delivering measurable gains in productivity, compliance, and decision-making.<\/p>\n<p>ArisGlobal introduced several new product innovations, including:<\/p>\n<ul type=\"disc\">\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=490648651&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2F&amp;a=LifeSphere%C2%AE+Unify\" target=\"_blank\" rel=\"nofollow\">LifeSphere\u00ae Unify<\/a>\u00a0\u2013 A next-generation R&amp;D compliance platform that brings Safety, Regulatory, Medical Affairs, and Quality into one cohesive ecosystem, enabling unparalleled interoperability, visibility, and decision support.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=66713719&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-announces-lifesphere-unify-navax-insights-and-advanced-compliance-docs%2F&amp;a=NavaX+Insights\" target=\"_blank\" rel=\"nofollow\">NavaX Insights<\/a>\u00a0\u2013 A contextual analytics engine that automatically synthesizes information from multiple structured and unstructured sources, surfacing hidden trends, emerging risks, and actionable signals across PV and Regulatory domains.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1143080633&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Farisglobal-launches-new-navax-agent-meddra-coding-powered-by-agentic-ai%2F&amp;a=NavaX+Agent+for+MedDRA+Coding\" target=\"_blank\" rel=\"nofollow\">NavaX Agent for MedDRA Coding<\/a>\u00a0\u2013 An agentic AI capability that mimics expert user behavior to deliver over 80% coding automation, reduce manual workloads, and ensure audit-ready traceability in the medical coding process.<\/li>\n<li><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1736081334&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Flifesphere%2Fsafety%2Fadvanced-compliance-docs%2F&amp;a=Advanced+Compliance+Docs\" target=\"_blank\" rel=\"nofollow\">Advanced Compliance Docs<\/a>\u00a0\u2013 A purpose-built automation engine for safety and regulatory documentation, streamlining the creation, storage, and collaboration of complex materials like PSMFs, PVAs, and aggregate safety reports.<\/li>\n<\/ul>\n<p>These additions reflect ArisGlobal&#8217;s broader commitment to delivering practical, production-ready AI use cases \u2014 with most modules able to be implemented in as little as three to six months.<\/p>\n<p>&#8220;Our approach to product development is grounded in solving real problems that our customers are facing today,&#8221; said <span class=\"xn-person\">Ann-Marie Orange<\/span>, CIO and Global Head of R&amp;D at ArisGlobal. &#8220;We&#8217;re moving fast, but with purpose \u2014 applying AI where it makes the biggest difference, and doing so in a way that ensures trust, traceability, and tangible results.&#8221;<\/p>\n<p><b>Leadership and Strategic Investment<\/b><br \/>In <span class=\"xn-chron\">May 2025<\/span>, ArisGlobal <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=2380997884&amp;u=https%3A%2F%2Fwww.arisglobal.com%2Fmedia%2Fpress-release%2Flucinda-smith-appointed-as-chief-safety-product-officer-at-arisglobal%2F&amp;a=appointed+Lucinda+Smith\" target=\"_blank\" rel=\"nofollow\">appointed <span class=\"xn-person\">Lucinda Smith<\/span><\/a> as Chief Safety Product Officer. Formerly Global Head of Safety Operations at Roche, Smith brings a deep understanding of the challenges facing today&#8217;s pharmacovigilance teams \u2014 and how technology can help address them. Her leadership reflects ArisGlobal&#8217;s continued investment in domain expertise and customer-centric product development.<\/p>\n<p>&#8220;Across the industry, regulatory pressure is intensifying, case volumes are climbing, and cost constraints are pushing teams to rethink how they work,&#8221; said <span class=\"xn-person\">Aman Wasan<\/span>, Chief Executive Officer of ArisGlobal. &#8220;Organizations are looking to simplify their IT ecosystems and turn to automation not just as a future goal, but as a necessity. Our AI-first approach \u2014 and our ability to help customers operationalize AI in real, tangible ways \u2014 is exactly why we&#8217;re seeing such strong customer adoption, and why the industry&#8217;s best talent is coming to ArisGlobal.&#8221;<\/p>\n<p><b>About ArisGlobal<\/b><br \/>ArisGlobal, an innovative life sciences technology company and creator of LifeSphere\u00ae, is transforming how today&#8217;s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in <span class=\"xn-location\">the United States<\/span>, ArisGlobal has regional offices in <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">India<\/span>, <span class=\"xn-location\">Japan<\/span>, and <span class=\"xn-location\">China<\/span>. For more updates, follow ArisGlobal on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=1844092706&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faris-global%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>. <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=3166715220&amp;u=https%3A%2F%2Fwww.arisglobal.com%2F&amp;a=www.arisglobal.com\" target=\"_blank\" rel=\"nofollow\">www.arisglobal.com<\/a>.\u00a0<\/p>\n<p>Logo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4477185-1&amp;h=88688840&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1510670%2F5435511%2FArisGlobal_Logo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1510670%2F5435511%2FArisGlobal_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnasia.com\/media2\/1510670\/5435511\/ArisGlobal_Logo.jpg?p=medium600<\/a><\/p>\n<p>\u00a0<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-17971","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/17971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17971"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/17971\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}